URB602,
565460-15-3,
URB602,
cyclohexyl biphenyl-3-ylcarbamate,
Cyclohexyl [1,1'-biphenyl]-3-ylcarbamate,
URB-602,
UNII-B8371SFA9K,
CHEMBL77767,
Monoacylglycerol Lipase Inhibitor, URB602,
biphenyl-3-ylcarbamic acid cyclohexyl ester,
B8371SFA9K,
URB 602,
N-Biphenyl-3-ylcarbamic acid, cyclohexyl ester,
N-[1,1'-Biphenyl]-3-yl-carbamic Acid Cyclohexyl Ester,
SCHEMBL4274165,
Cyclohexylbiphenyl-3-ylcarbamate,
CTK8C4433,
DTXSID90450611,
HHVUFQYJOSFTEH-UHFFFAOYSA-N,
BCP19101,
EX-A1228,
ANW-71925,
BDBM50128581,
IN1230,
MFCD08457914,
ZINC13520725,
AKOS016007303,
CS-6057,
TRA0087812,
AJ-64041,
AK-61367,
Cyclohexyl [1,1-biphenyl]-3-ylcarbamate,
SC-66798,
URB602, >=98% (HPLC),
AX8217407,
HY-100792,
RT-013931,
Biphenyl-3-yl-carbamic acid cyclohexyl ester,
FT-0675735,
X6362,
A16359,
Biphenyl-3-yl Carbamic Acid, Cyclohexyl Ester,
Carbamic acid, N-(1,1'-biphenyl)-3-yl-, cyclohexyl ester,
[1,1 inverted exclamation mark -Biphenyl]-3-yl-carbamic acid cyclohexyl ester,
cyclohexyl ester,
D0W1OX,
C19H21NO2,
Cyclohexyl N-(3-phenylphenyl)carbamate,
[1,1'-Biphenyl]-3-yl-carbamic acid,
CB11138,
CID10979337,
Cyclohexyl[1,1'-biphenyl]-3-ylcarbamate,
C501835,